Cholangitis, Sclerosing Clinical Trial
OBJECTIVES:
I. Evaluate the effects of cladribine (2-chlorodeoxyadenosine; 2-CdA) on biochemical,
radiologic, and histologic parameters in patients with early stage primary sclerosing
cholangitis.
PROTOCOL OUTLINE:
Patients are treated with subcutaneous injections of cladribine (2-chlorodeoxyadenosine;
2-CdA) for 5 consecutive days every month for 3 months.
;
Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01456468 -
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
|
Phase 1 | |
| Terminated |
NCT03359174 -
An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis
|
Phase 2 | |
| Completed |
NCT00004842 -
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
|
Phase 1 | |
| Completed |
NCT00587236 -
Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis
|
N/A | |
| Withdrawn |
NCT03678480 -
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
|
Phase 2 | |
| Recruiting |
NCT03146936 -
Swiss Primary Sclerosing Cholangitis Cohort Study
|
||
| Recruiting |
NCT00160940 -
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
|
N/A | |
| Recruiting |
NCT02997878 -
Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04181138 -
Primary Sclerosing Cholangitis in Children
|
||
| Completed |
NCT02967926 -
Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
|
Phase 3 |